WCTE is a biopharmaceutical company developing novel formulations of active ingredients of Pterostilbene and other NAD modulators of known safety. Our products and services will focus on the well being of both the neurological and immune systems of the general public but with an immediate focus on NFL players, soccer players, boxers, and military veterans; both active and retired. While we make no claims, we believe that in 3-5 years we can reverse the effects that exist within this 80 billion dollar epidemic.
WCTE has assembled a high caliber team of scientists, physicians, and marketing experts to lead the development and commercialization of these products. Our scientific approach will also focus on pipeline products to address inflammation related conditions of other organs (skin, liver, etc.). WCTE is currently focused on Chromatic Traumatic Encephalopathy, which is an accelerated form of Alzheimer’s better known as CTE and often found in NFL players and victims of Traumatic Brain Injury (TBI). Former and current NFL players are at a major disadvantage today not having access to a base product aimed at prevention and “quality of life” solutions for the effected population. Soccer players are also affected as well as boxers who have been known to acquire a condition called “Punch Drunk Syndrome”. Military Veterans suffer from the effects of PTSD. WCTE’s call to action centers around societal issues that a segment of our population has to confront on a daily basis; the effects of CTE, inflammation, depression, memory loss, aggressive behavior, imperativeness, suicide and other maladies. It is, without question, our commitment to improve brain health and neurodegenerative conditions in people worldwide.